Clinical Impact of Switching to Ceritinib After Severe AEs Related to Crizotinib/Alectinib in a Novel PTH2R-ALK Fusion Lung Adenocarcinoma: A Case Report

Shen G, Du Y, Shen J, Zhang J, Xia X, Huang M, Shen W

OncoTargets and Therapy 2021, 14:5471-5475

Published Date: 23 December 2021